Member Info for HereforHemo

So you repeatedly sell in 500k blocks on the back of no volume and you’re shocked the SP goes down. What the **** did you think would happen, we’d hit a yearly high???

As we’re mentioning individuals and companies involved with HEMO, it’s worth noting this guy. I expect him to have a major impact on the progress and direction of the company in the weeks and months ahead. I got one don’t think they’re moving into a huge new laboratory without a very good reason.

https://hemogenyx.com/investors/investors/announcements/announcement/2021/appointment-of-business-advisor-board-observer/

one2one Of course that is a possibility. Or another possibility is that with a Chairman such as Sir Marc Feldmann and a Scientific Advisor such as Dr Shepard, who are the equivalent of Nobel prize winners in the USA, and responsible for bringing two of the best selling drugs in the world to market, coupled with the collaboration with Penn University, arguably the world leaders in CAR-T therapy, that Hemogenyx wouldn’t have requested the meeting with the FDA unless they were extremely confident it would fly through and they’re ready to commence clinical trials. I suppose your point of view depends on whether you’re short or not. :)

Always love it when people sell then throw in I think it will go lower, but hope it doesn’t. Yeah right. Enjoy your trading.

JHFH That’s the problem right there. Vlad said in his June Podcast that a CBR update would be ‘soon’. Trouble is with him is he doesn’t understand the English definition of what he says. Similar I suppose to the SP being a ‘temporary blip’. Take the rose tinted glasses off and analyse what they say to what they do. Where’s this ‘miracle worker’ they were employing? We’re just constantly being fed a load of *******s, in my opinion anyway.

Check I still think we have LTHs who are still in profit that are selling/trading it all the way down. The usual suspects usually buy back in so not too much of a concern to me. Well it is but nothing anyone can do about it lol. The problem here is really Vlad and his stance of running HEMO as if it were a private company, and that he’s responsible to no one. Well he is, he has a responsibility to shareholders! He has a duty to provide regular and timely updates and despite many promises had failed to deliver anything meaningful for getting on for a year, the exception being the recent RNS on CAR-T. I recently responded to his tweet criticising shareholders by suggesting maybe it’s the Shareholders that need a more sophisticated CEO. Didn’t go down too well as he promptly blocked me lol. That being said I’ll hold until next year until I either make a fortune or lose everything. I’ll only give up when my HL fees exceed my investment lol. Ho hum.

Pawn I get where you are coming from that’s for sure! Sir Marc did indeed say the inflection point would be this year. Vlad even tweeted saying this would be ‘the most exciting year ever’. They promised updates on CAR-T partners ‘one of which would be a famous name’ and an update on CBR..and those were promised nearly six months ago now, and as yet absolutely nothing. But there is no doubt the science has progressed. Unfortunately it’s like pulling teeth holding this atm but by the end of Q1 it will have been two years working on CBR and the initial FDA meeting would have taken place for CAR-T. Maybe a CDX update and a non dilutive finance package coming as well. Surely around the bottom now so if you don’t have to sell, might be worth another quarter to see if you can recover some losses? If you decide on selling, good luck to you mate!

Got a message from a good friend who I haven’t seen for a while. He said tell that HFH that two of the 5K buys for HEMO today were mine. I asked him how he knew HFH was me and he said cause I know you lol. Anyway he said he dipped into Casper Sunrise at 1.95 and bailed at 4.00, so well done him. He’s in for HEMO next year, as am I. I know you read the BB everyday mate so hopefully you’ll be able to trade that Austin Martin in for a decent German car next year lol. Good luck mate!

Pumpky Doesn’t matter to me who has sold or why. Focus just on your own investment, that’s all that matters. You either believe in the science or you don’t, nothing else matters.

Thx Micky, I appreciate that.
The bottom line here is that Vlad, with millions in the bank, doesn’t give a toss what the current SP is, no matter how painful to shareholders. He’s focused purely on the science, purely on getting candidates into clinical trials and ultimately saving and improving peoples lives. Shareholders have given him the capability to do that. He states the SP will follow and if you believe in what the company is doing it must surely do so. Big balls required but all things being equal this must turn to the upside in Q1. As always just my personal opinion.

Micky It has indeed been a horrible year, not only from this company but virtually all small caps. Nothing we can do about it my friend, just got to hope for a better year next year. Stay calm mate as getting angry will cloud your judgement. We’re all frustrated but let’s try to stay friendly on here as we’ve all got enough **** to deal with as it is.

Brent Whilst nobody can argue with what Vlad has done over the past year or so, you must remember their are other members of Hemogenyx, such as Marc Feldmann and Dr Shepard who are vastly experienced, in fact responsible for bringing two of the worlds best selling drugs to market, along with Dr Walts who has raised hundreds of millions in financing within the BioPharma sector. We can’t look back, what’s done is done but my view is the science has benefited from monies raised, they ARE progressing CAR-T and CDX into clinical trials and appear very confident these drugs will work. Yes it’s high risk BUT they are funded for these trials, they will happen in the months ahead and IF they do indeed work each is a billion dollar drug. They also have their wildcard CBR. With Omicron looking far more deadly than people first thought, any positive update on this will see a substantial rerate on that alone. Minimal downside from here with tremendous upside potential. So two choices, be patient or sell up and take the loss. I know what I’m doing..good luck whatever people decide.

Couldn’t be clearer where this is going..

https://finance.yahoo.com/news/hemogenyx-pharmaceuticals-plc-announces-hemo-092000998.html

Personally I’m not sure they are short term traders driving the price down. I think it far more likely that Vlad really ****ed off some LTH’s with one of his recent tweets and they have just lost patience. For those looking at the long term picture, although frustrating, it really should be of no concern. In a matter of a few months Hemogenyx will move into being a clinical company and for pharma that is a blink of an eye away. More fool those who take comments personally and trade on emotion. Just my opinion.

JHFH It is my understanding HEMO have already started the process of contacting doctors so I think from IND application into trials is going to be pretty quick. Here’s hoping!

Think the important thing to realise is that previous CAR-T submissions in collaboration with Penn University were given expedited approval by the FDA due to their medical importance. My view is Hemogenyx are very close to moving from R&D into a Clinical company, around six months away imo and when they do the peer level is around 17p. That’s without CDX and CBR. Gonna be a great 2022. Just my opinion.

Interesting to see all attendees tweeting about their excitement of being there, what they are discussing and links to their websites. Apart from Hemogenyx that is, who typically say nothing. Still a lot of work to do on the PR front. :(

Final stage of pre-clinical work underway before IND application and clinical trials.

https://ash.confex.com/ash/2021/webprogram/Paper151196.html

Transformational when Hemogenyx get CAR-T into clinical trials next year. Very expensive therapy.

https://www.fiercepharma.com/pharma/kite-pharma-s-car-t-drug-could-feature-a-budget-busting-649k-price-tag-report

Trek I’m sure most would agree to trade 25-30% of your holding on news spikes is a sensible thing to do. Unfortunately it’s far too risky a strategy for those underwater, hence why it’s so critical to get your entry point right on any stock, and good luck to you for doing that here. However, I think you’d gain a little more credibility if you realised that Hemogenyx is not actually listed on AIM.